Cargando…
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
HIV-1 persists indefinitely in people living with HIV (PLWH) on antiretroviral therapy (ART). If ART is stopped, the virus rapidly rebounds from long-lived latently infected cells. Using a humanized mouse model of HIV-1 infection and CD4(+) T cells from PLWH on ART, we investigate whether antagonizi...
Autores principales: | Arandjelovic, Philip, Kim, Youry, Cooney, James P., Preston, Simon P., Doerflinger, Marcel, McMahon, James H., Garner, Sarah E., Zerbato, Jennifer M., Roche, Michael, Tumpach, Carolin, Ong, Jesslyn, Sheerin, Dylan, Smyth, Gordon K., Anderson, Jenny L., Allison, Cody C., Lewin, Sharon R., Pellegrini, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518630/ https://www.ncbi.nlm.nih.gov/pubmed/37652018 http://dx.doi.org/10.1016/j.xcrm.2023.101178 |
Ejemplares similares
-
The Growing Role of the BH3 Mimetic Drug Venetoclax in the Therapy of Acute Myeloid Leukemia
por: Pelosi, Elvira, et al.
Publicado: (2022) -
Mitochondrial apoptosis and BH3 mimetics
por: Dai, Haiming, et al.
Publicado: (2016) -
BH3 Mimetics in Hematologic Malignancies
por: Klener, Pavel, et al.
Publicado: (2021) -
The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells
por: Li, Zhaodong, et al.
Publicado: (2018) -
On BH3 Mimetics and Ca(2+) Signaling
por: Ferdek, Pawel E., et al.
Publicado: (2017)